Mohamad, A. F. (2024) “RISK OF KETOACIDOSIS WITH LUSEOGLIFLOZIN IN TYPE 2 DIABETES MELLITUS PATIENTS ON MODERATE DOSE INSULIN THERAPY: A RANDOMISED CONTROL TRIAL”, Journal of the ASEAN Federation of Endocrine Societies, 39(S1), pp. 34–35. doi: 10.15605/jafes.039.S1.053.